Serina Therapeutics, Inc.
SER
$3.79
-$0.02-0.53%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -425.18% | -223.90% | 67.95% | -360.70% | -19.52% |
| Total Depreciation and Amortization | -71.43% | -71.93% | -32.00% | 833.33% | 3.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 87.78% | 122.47% | -99.85% | -153.79% | -99.50% |
| Change in Net Operating Assets | 26.22% | 114.75% | -14.95% | 31.20% | 2,226.92% |
| Cash from Operations | -29.98% | 53.18% | -174.06% | -3,892.56% | -189.26% |
| Capital Expenditure | -333.33% | -- | -- | 92.86% | 97.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -333.33% | -- | -- | 92.86% | 97.48% |
| Total Debt Issued | 61,312.50% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 92.31% | 33.33% |
| Issuance of Common Stock | 1,680.23% | -87.37% | -75.00% | -- | 514.29% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 1,358.75% | -- | -- |
| Cash from Financing | 7,393.02% | 3.78% | 80.24% | 38,800.00% | 4,200.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 189.58% | 167.15% | -47.67% | 1,050.00% | -152.32% |